Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

Once a week, Sun Kai has a video call with his mother, and they discuss his day-to-day life. But Sun’s mother died five years ...

CRISPR-based therapies are also being developed for in vivo use, in which the gene editing ... of $2.2 million for both TDT and SCD. It is an alternative to bluebird bio’s Zynteglo ...

Many may be familiar with the new dean of the College of Natural and Agricultural Sciences, or CNAS. Peter Atkinson, a professor of genetics in the Department of Entomology, has been with UCR for 28 ...

Metabolic engineering is the use of genetic engineering to modify the ... tubulosa and synthesize 23 PhGs in tobacco. Applying the CRISPR-Cas9 system to edit high GC content genomes has been ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

which "barcodes" cells and uses CRISPR to systematically turn off individual genes to study their function in those cells. The new technique lets scientists study the effects of perturbing over ...

Financial writer discusses MGX's gene editing technology, cash runway, and lack of clinical data for potential future ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Advancements and Projections in the Global Zebrafish for Market: Insights, Trends, Opportunities, and Recent DevelopmentsNew ...

CRISPR Therapeutics is a mid-stage biotech specializing in gene editing. It became the first gene-editing treatment that uses the Nobel Prize-winning CRISPR technique, an impressive achievement by ...